[PRESS RELEASE] – EDMONTON, Alberta, Feb. 11, 2026 – Aurora Cannabis Inc., the Canadian-based leading global medical cannabis company, is expanding its Aurora medical portfolio in Australia and New Zealand, delivering patients and prescribers enhanced choice, reliable quality and easier access to science-backed products. The expansion underscores the company's ongoing dedication to meeting the unique needs of patients and health care professionals in the region, reflecting Aurora's strategic focus on long-term global growth.
The expansion in New Zealand this month includes two new THC flower products, Big Wave and Night Ride, as well as the balanced strain Half Moon, coming soon in Q1 FY27. The brand will also debut four new resin cartridges in Australia this month, including Chemango Kush, Cosmic Cream, Lunar Express and Soul Train Haze.
"With Australia being one of our largest international medical cannabis market, both Australia and New Zealand remain a top priority for Aurora, and we are deeply committed to our continued investment across the region," said Stanley Sack, interim managing director of MedReleaf Australia. "As patient needs evolve, so does our responsibility to deliver high-quality, diversified product formats that support prescribers in delivering better care. Our focus on quality and reliable supply reflects our dedication to ensuring patients have meaningful access to the products they depend on."
Each new product is derived from Aurora's proprietary genetics and manufactured at the company's leading EU-GMP and TGA-GMP-certified facilities in Canada, ensuring the highest standards of quality and safety.
New Zealand Launches:
- Big Wave™ – Flower, Hybrid, THC 26%, CBD <1%
- Night Ride™ – Flower, Indica, THC 29%, CBD <1%
- Half Moon™ – Flower, Hybrid, THC 9%, CBD 13%
Australia Launches:
- Chemango™ Kush – Resin Cartridge, Indica, THC 780mg/g, CBD <10mg/g
- Cosmic Cream™ – Resin Cartridge, Indica, THC 780 mg/g, CBD <10mg/g
- Lunar Express™ - Resin Cartridge, Indica, THC 780mg/g, CBD <10mg/g
- Soul Train Haze™ – Resin Cartridge, Sativa, THC 780mg/g, CBD <10mg/g
Aurora remains a trusted choice for prescribers and patients around the globe. With a broad portfolio of high-quality medical cannabis, proven regulatory expertise and strong leadership across a dozen markets, Aurora continues to raise the bar for supporting patient care.
